FYERS
Gennex Laboratories9.36
-0.02 (+6.97%)

Gennex Laboratories Share Price

9.36-0.02 (+6.97%)
-38.05% past 1 Year

Corporate filings & documents

Announcements

Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve 1. Consider and adopt the Unaudited Financial Statements (Standalone and Consolidated) for the Quarter and Half Year ended September 30 2026;2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter and Half-Year ended September 30 2026;3. Other Business items.
1 day ago
With reference to the captioned subject matter pursuant to regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Share Transfer Agent of the Company for the Quarter ended September 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
3 weeks ago
With reference to the captioned subject matter pursuant to regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Share Transfer Agent of the Company for the Quarter ended September 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
3 weeks ago
In compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time please find enclosed herewith voting results of the 41st eAGM of the Company held on September 30 2026 at 12.30 Hrs through VC/OAVM along with the consolidated Scrutinizers report.It is to inform that all resolutions set out in the notice of the 41st eAGM were duly approved by shareholders with requisite majority. The voting results along with Scrutinizers report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
In compliance to Regulation 44 of SEBI (LODR) Regulations 2015 as amended from time to time please find enclosed herewith voting results of the 41st eAGM of the Company held on September 30 2026 at 12.30 Hrs through VC/OAVM along with the consolidated Scrutinizers report.It is to inform that all resolutions set out in the notice of the 41st eAGM were duly approved by shareholders with requisite majority. The voting results along with Scrutinizers report is also being enclosed to this letter and uploaded on the website of the Company i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01 2026 in place of retiring Independent Non Executive Director Mr. Amudala Sreeramulu Nageswar Rao whose current period of office has expired on the date of AGM i.e. September 30 2026.The relevant details of the captioned appointment and retirement are given in the enclosed Annexure A along with disclosure in Form B under SEBI (PIT) Regulations 2015.We request you to take note of the above information on record and acknowledge receipt of the same.
1 month ago
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations 2015 we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01 2026 in place of retiring Independent Non Executive Director Mr. Amudala Sreeramulu Nageswar Rao whose current period of office has expired on the date of AGM i.e. September 30 2026.The relevant details of the captioned appointment and retirement are given in the enclosed Annexure A along with disclosure in Form B under SEBI (PIT) Regulations 2015.We request you to take note of the above information on record and acknowledge receipt of the same.
1 month ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday September 30 2026 through VC and OAVM. The meeting was held in compliance to the General Circular no. 03/2025 dated September 22 2025 issued by MCA and Circular no. 2024/133 dated October 03 2024 issued by SEBI Companies are allowed to hold AGM through VC and OAVM without the physical presence of members at a common venue till further notice and other applicable provisions of the Companies Act 2013 read with rules made thereunder. The meeting commenced at 12.30 Hrs and concluded at 01.26 Hrs. All the requisite Statutory registers and other requisite documents were available electronically during the AGM for inspection by the members.The intimation is also uploaded in the Company website: www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday September 30 2026 through VC and OAVM. The meeting was held in compliance to the General Circular no. 03/2025 dated September 22 2025 issued by MCA and Circular no. 2024/133 dated October 03 2024 issued by SEBI Companies are allowed to hold AGM through VC and OAVM without the physical presence of members at a common venue till further notice and other applicable provisions of the Companies Act 2013 read with rules made thereunder. The meeting commenced at 12.30 Hrs and concluded at 01.26 Hrs. All the requisite Statutory registers and other requisite documents were available electronically during the AGM for inspection by the members.The intimation is also uploaded in the Company website: www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of he Company shall remained closed from October 01 2026 till 48 hours after the Public announcement through Board of Directors in their meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the Second quarter and Half year ended on September 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Unaudited Standalone and Consolidated Financial results of the Company for Second quarter and Half year ended on September 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.
1 month ago
Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of he Company shall remained closed from October 01 2026 till 48 hours after the Public announcement through Board of Directors in their meeting held for announcing the Unaudited Standalone and Consolidated Financial Results for the Second quarter and Half year ended on September 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Unaudited Standalone and Consolidated Financial results of the Company for Second quarter and Half year ended on September 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.
1 month ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09 2026 for the 41st Annual General Meeting of the Company to be held on September 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication of AGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Telugu - Local) on September 09 2026 for the 41st Annual General Meeting of the Company to be held on September 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
1 month ago
We are pleased to inform that our subsidiary company M/s Deccan Remedies Limited has received approval from the Drugs Control Administration Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination test or analysis under Form 29. Approval received from DCA Government of Andhra Pradesh is enclosed herewith for your information and for taking the same on record.
1 month ago
We are pleased to inform that our subsidiary company M/s Deccan Remedies Limited has received approval from the Drugs Control Administration Government of Andhra Pradesh granting License for Manufacturing of additional Products under form 25 and Test License for the purpose of examination test or analysis under Form 29. Approval received from DCA Government of Andhra Pradesh is enclosed herewith for your information and for taking the same on record.
1 month ago
With reference to the subject matter As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31 2026 inter alia Notice of the Annual General Meeting to be held on Wednesday September 30 2026 Directors Report Independent Audit Report of Statutory Auditor Financial Statements (Standalone and Consolidated) being Balance Sheet Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e. www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours.This intimation is also being uploaded on the Company website: www.gennexlab.com.
1 month ago
With reference to the subject matter As per the Regulation 34 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we hereby submits 41st Annual Report of Gennex Laboratories Limited for the Financial Year ended March 31 2026 inter alia Notice of the Annual General Meeting to be held on Wednesday September 30 2026 Directors Report Independent Audit Report of Statutory Auditor Financial Statements (Standalone and Consolidated) being Balance Sheet Statement of Profit and Loss account & Cash Flow Statement along with the Notes thereto for the Financial Year ended March 31 2026 have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e. www.gennexlab.com and are also available for inspection at the Registered Office of the Company during office hours.This intimation is also being uploaded on the Company website: www.gennexlab.com.
1 month ago
Pursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23 2026 to September 30 2026 (both days inclusive) for the purpose of 41sr Annual General Meeting to be held on Wednesday September 30 2026.The intimation is also being uploaded on the Company website i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
2 months ago
Pursuant to Regulation 42 of SEBI (LODR) Regulations 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23 2026 to September 30 2026 (both days inclusive) for the purpose of 41sr Annual General Meeting to be held on Wednesday September 30 2026.The intimation is also being uploaded on the Company website i.e. www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.
2 months ago
1. Draft Directors/ Board Report for the Financial Year March 31 2026;2. The 41st Annual General Meeting of the Company to be held on Wednesday September 30 2026 at 12:30 P.M. through (VC/OAVM);3. Appointment of Ms. Sweety Kapoor Practicing Company Secretary Kolkata as Scrutinizer for the AGM;4. Book Closure Date in connection with 41st AGM between September 23 2026 to September 30 2026;5. Appointment of NSDL as authorized agency for facilitating 41st AGM and providing E- Voting facility;6. E-voting period from Sunday September 27 2026 at 9.00 AM to Tuesday September 29 2026 at 5.00 PM with cut-off date September 23 2026;7. Secretarial Audit Report issued by Mr. Md. Tausif Shamim Practicing Company Secretary Kolkata;8. Cost Audit Report issued by M/s. Sai Krishna & Associates Cost Accountants for the year ended March 31 2026;9. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM.
2 months ago
1. Draft Directors/ Board Report for the Financial Year March 31 2026;2. The 41st Annual General Meeting of the Company to be held on Wednesday September 30 2026 at 12:30 P.M. through (VC/OAVM);3. Appointment of Ms. Sweety Kapoor Practicing Company Secretary Kolkata as Scrutinizer for the AGM;4. Book Closure Date in connection with 41st AGM between September 23 2026 to September 30 2026;5. Appointment of NSDL as authorized agency for facilitating 41st AGM and providing E- Voting facility;6. E-voting period from Sunday September 27 2026 at 9.00 AM to Tuesday September 29 2026 at 5.00 PM with cut-off date September 23 2026;7. Secretarial Audit Report issued by Mr. Md. Tausif Shamim Practicing Company Secretary Kolkata;8. Cost Audit Report issued by M/s. Sai Krishna & Associates Cost Accountants for the year ended March 31 2026;9. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 05:00 PM.
2 months ago
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To decide regarding the conduct of 41st AGM for the year ended March 31 2026;2. To Consider and Appoint Scrutinizer of the 41st Annual General Meeting in case of Finalisation of the Date of AGM;3. Any other business with permission of the Chairperson.
2 months ago
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 inter alia to consider and approve 1. To decide regarding the conduct of 41st AGM for the year ended March 31 2026;2. To Consider and Appoint Scrutinizer of the 41st Annual General Meeting in case of Finalisation of the Date of AGM;3. Any other business with permission of the Chairperson.
2 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 announced by the Board of Directors in its meeting held on Friday August 14 2026. Financial results had been published in both Business Standard (English) and Saksham (Telugu - Local) on August 15 2026.We request you to take the above information on record and acknowledge receipt of the same.
2 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 announced by the Board of Directors in its meeting held on Friday August 14 2026. Financial results had been published in both Business Standard (English) and Saksham (Telugu - Local) on August 15 2026.We request you to take the above information on record and acknowledge receipt of the same.
2 months ago
In just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended June 30 2026.2. Limited Review Reports from Statutory auditors on Unaudited Standalone and Consolidated Financial Statement for Quarter ended June 30 2026.3. Other itemsWe hereby submit that the meeting had commenced at 4.00 PM and concluded at 4.40 PM.
2 months ago
In just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Unaudited Standalone and Consolidated Financial Statement for the Quarter ended June 30 2026.2. Limited Review Reports from Statutory auditors on Unaudited Standalone and Consolidated Financial Statement for Quarter ended June 30 2026.3. Other itemsWe hereby submit that the meeting had commenced at 4.00 PM and concluded at 4.40 PM.
2 months ago
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
2 months ago
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter ended June 30 2026 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 4.40 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
2 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
3 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026.We request you to take the above information on record and acknowledge receipt of the same.
3 months ago
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.
3 months ago
Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.
3 months ago
With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
3 months ago
With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026.We request you to take the above information on record and acknowledge the receipt of the same.
3 months ago
Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of the Company shall remain closed from July 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended on June 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ending on June 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record.
4 months ago
Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of the Company shall remain closed from July 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the First Quarter ended on June 30 2026 along with other matters for which Trading Window is required to be closed.The Board Meeting date to approve the Un-audited Standalone and Consolidated Financial Results of the Company for the first quarter ending on June 30 2026 will be informed in due course.All Promoters/designated/connected persons are advised not to trade in the securities of the Company either directly or indirectly during the aforesaid period of Closure of Trading Window.We request you to take the above information on record.
4 months ago
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 10 2026 for Premier Fiscal Services Pvt Ltd
4 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Audited (Standalone and Consolidated) Financial Results for the Quarter and year ended March 31 2026 announced by the Board of Directors in its meeting held on May 30 2026. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on June 01 2026.We request you to take the above information on record and acknowledge receipt of the same.
5 months ago
Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper publication on Audited (Standalone and Consolidated) Financial Results for the Quarter and year ended March 31 2026 announced by the Board of Directors in its meeting held on May 30 2026. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on June 01 2026.We request you to take the above information on record and acknowledge receipt of the same.
5 months ago
In just concluded Meeting of Board of Directors the Board approved and considered the following items:1. Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31 2026.2. Auditors Report on audited Standalone and Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone and Consolidated) are attached herewith.We hereby submit that the Board Meeting had commenced at 4:00 pm and concluded at 7:30 pm.This intimation is also uploaded on the company website www.gennexlab.com
5 months ago
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended March 31 2026;2. Auditors Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached herewith - Annexure I;We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 7.30 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
5 months ago
In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Audited Standalone & Consolidated Financial results for the Quarter & Year Ended March 31 2026;2. Auditors Report on audited Standalone & Consolidated Financial Statements for the Quarter and Year ended March 31 2026 issued on dated May 30 2026 along with the Statement on Impact of Audit Qualification (Standalone & Consolidated) are attached herewith - Annexure I;We hereby submit that the Board Meeting had commenced at 4:00 PM and concluded at 7.30 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.
5 months ago
In compliance with Regulation 24A of SEBI (LODR) Regulations 2015 Board appointed M/s. Mohammed Tausif Shamim & Co. practicing Company Secretary Kolkata as Secretarial Auditor of the Company for the Financial Year ended March 31 2026. They carried out the Secretarial Audit and submitted the Annual Secretarial Compliance Report with reference to the SEBI circular 27/2019 dated 8th February 2019.We hereby submit the Annual Secretarial Compliance Report issued by the Secretarial Auditor within the timeline allowed by SEBI vide Circular No.2021/556 dated 29th April 2021.We request you to take the above information on record and acknowledge the receipt of the same.
5 months ago
In compliance with Regulation 24A of SEBI (LODR) Regulations 2015 Board appointed M/s. Mohammed Tausif Shamim & Co. practicing Company Secretary Kolkata as Secretarial Auditor of the Company for the Financial Year ended March 31 2026. They carried out the Secretarial Audit and submitted the Annual Secretarial Compliance Report with reference to the SEBI circular 27/2019 dated 8th February 2019.We hereby submit the Annual Secretarial Compliance Report issued by the Secretarial Auditor within the timeline allowed by SEBI vide Circular No.2021/556 dated 29th April 2021.We request you to take the above information on record and acknowledge the receipt of the same.
5 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Gennex Laboratories Ltd Share Price Today

The Gennex Laboratories Ltd share price today is ₹9.74. During the trading session, the Gennex Laboratories Ltd share price opened at ₹10.06 and recorded an intraday high of ₹10.07 and a low of ₹9.7. Last closing price was ₹9.95. Over the past 52 weeks, the Gennex Laboratories Ltd share price has ranged between ₹7.05 and ₹17.25. The current Gennex Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.